Background: Scaling and root planing is the basic treatment modality for periodontal disease. However, mechanical treatment is limited by physical impediments and biochemical considerations. Herbal agents may be used as an adjunct to overcome limitations of mechanical therapy. Thus the aim of this research was to evaluate the effect of Aloin, (aloevera extract) as a local drug delivery (LDD). LDD was used as an adjunct to scaling and root planing (SRP). Study was aimed to compare the clinical and microbiological effect of Aloin on the levels of Porphyromonas gingivalis (P.gingivalis) and Aggregatibacter actinomycetemcomitans (A.A comitans) in the treatment of chronic generalized periodontitis (CGP). Methods: Thirty chronic generalized periodontitis patients with 90 sites were selected including both males and females in the age group of 25-55 years. Three groups were made, 30 sites in each group were assigned. Group A was treated with aloin alone as LDD. Group B was treated with SRP and Aloin, whereas Group C was treated with SRP alone. Plaque sample was collected on baseline, 15 th , 30 th day for quantitative and qualitative analysis of P.gingivalis and A.A comitans. Results: There was a statistically significant improvement in all clinical and microbiological variables, including plaque and gingival index. However greatest improvement was evident in Group B in terms of reduction in colony forming units(CFU) of P.gingivalis and A.A comitans. Conclusion: Aloin as LDD is a valuable adjunct to SRP in the treatment of chronic generalized periodontitis.
Aim:Among various dental ailments, periodontitis has always had a towering popularity. The inauguration of new classification scheme for periodontal diseases and conditions in 2017 World Workshop has a remarkable impact on the diagnosis of periodontal diseases worldwide. This study is based on comparison between the two classifications by American Academy of Periodontology for diagnosing periodontitis.Materials and Methods:This study focuses on the prevalence estimates of periodontitis by diagnosing the periodontal diseases using two different criteria simultaneously: the first criterion was based on the classification approved in 1999 World Workshop and the other criterion was based on the new classification scheme of periodontal diseases and conditions in 2017 World Workshop.Results:It was found that there was significant reduction in the prevalence estimates (P < 0.001) of periodontitis following the new classification scheme.Conclusion:The new classification scheme recognizes the clinical salience of periodontitis and is more likely to influence the treatment modality of long sufferings of the patients having periodontal problems across the globe. The new classification will also lay the base for future research in the field of dentistry. More future studies are required to assess the prevalence of periodontitis following new classification scheme on a larger scale.
Background: Periodontal regeneration remains one of the crucial issues in the field of periodontology. Periodontal intrabony defects could be treated by surgical intervention through various alloplastic bone graft substitutes. The Food and Drug Administration approved, Novabone putty is one of the recently marketed bone graft substitutes, which has been used in the present study. This study also incorporates the placement of platelet-rich fibrin (PRF) in combination with Novabone putty. Materials and Methods: Twenty patients were included in the study and were allocated to either Group A or Group B through randomization. Group A included the placement of Novabone putty in the periodontal intrabony defects, whereas Group B included the placement of Novabone putty along with PRF. Statistical analysis of plaque index, gingival index, probing pocket depth, relative attachment level, and intraoral periapical radiographs was performed. Results: Statistical more significant difference (P < 0.05) in probing pocket depth, and relative attachment level was observed in Group B (Novabone putty and PRF) in comparison to Group A (Novabone putty). Conclusion: Evaluation of efficacy of Novabone putty along with PRF produced more favorable results in relative attachment level gain and more reduction in probing pocket depth when compared to Novabone putty alone.
Introduction : Gingival black triangles are cosmetic deformities which occur due to loss or absence of interdental papilla, so reconstruction of interdental papilla have always been a challenging task in esthetic dentistry. This study aims to compare injectable platelet rich brin and hyaluronic acid injections in the treatment of gingival black triangles. Material and Methods : 40 sites were divided into two groups ; Group A and Group B. In Group A, Injectable platelet rich brin was deposited whereas in Group B hyaluronic acid injections were deposited. All the sites were examined for gingival index, plaque index, Papillae presence index and Black triangle area at baseline, 1 month and 3 months follow up. Results : On statistical analysis of the recorded data, results revealed statistical signicant difference in both the groups in Papillae presence index and Black triangle area from baseline to 1 month and 3 months follow up. Conclusion : Injectable Platelet rich brin can be a viable alternative to hyaluronic acid injections in the treatment of gingival black triangles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.